[1] 王刚, 范雪莉综述.可溶性白介素-2受体与皮肤病.国外医学皮肤性病学分册, 1993,19=338.
[2] 全国中西医结合皮嵌性病学会色素病学组.色丧风临床分型及疗效标准(草案).中华皮肤科杂志, 1995,28:212.
[3] 富宁, 王莉, 杨贵贞.单克隆与多克隆双抗体夹心法测定血清可溶性IL-2受体.中国免疫学杂志.1991.71278.
[4] 傅爱华, 陈世义, 陈维梅, 等.白瘫风患者的可溶性白细胞介素2受体研究.中国皮肤性病学杂志,1994,8:144.
[5] 徐小坷, 陈智, 何云志, 皮节型及非皮节型白瘫风临床、外周血T淋巴细胞亚群及自身抗体的观察.临床皮肤科杂志, 1991,201178.
[6] Rubin LA, Nelson DL. The soluble interleukin-2 receptor:biology, function, and clinical application. Ann Intern Med,1990,13:619.
[7] Le Poole IC, Das PK, van den Wijngaard RMJGJ, et al. Review of the etiopathomechanism of vitiligo:a convergence theory. Exp Dermatol, 1993,21145.
[8] Al Radri AMT, Todd PM, Garioch JJ, et al. An immunohistological study of cutaneous lymphocytes in vitiligo. J Pathol. 1993.170:149. |